Agonist Activation of Orphan Receptor GPR52 Opposes Dopamine D2 Receptor Signaling and Neuromodulation in the Nucleus Accumbens

被引:0
|
作者
Allen, John [1 ]
Murphy, Ryan [1 ]
Dvorak, Nolan M. [1 ]
Laezza, Fernanda [1 ]
机构
[1] Univ Texas Med Branch, Galveston, TX 77555 USA
关键词
Orphan Receptors; Schizophrenia; Dopamine; Anti-psychotics; cAMP Signalling; Nucleus Accumbens Core; Dopamine D2 Receptors;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
P561
引用
收藏
页码:390 / 391
页数:2
相关论文
共 50 条
  • [1] Orphan Receptor GPR52 Profoundly Modulates Dopamine D2 Receptor Signaling: Discovery of GPR52 Druglike Agonists With Antipsychotic Activity
    Allen, John
    Felsing, Daniel
    Murphy, Ryan
    Wang, Pingyuan
    Cunningham, Kathryn
    Zhou, Jia
    NEUROPSYCHOPHARMACOLOGY, 2021, 46 (SUPPL 1) : 376 - 376
  • [2] κ-Opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effects of cocaine
    Thompson, AC
    Zapata, A
    Justice, JB
    Vaughan, RA
    Sharpe, LG
    Shippenberg, TS
    JOURNAL OF NEUROSCIENCE, 2000, 20 (24) : 9333 - 9340
  • [3] Increasing dopamine D2 receptor expression in the adult nucleus accumbens enhances motivation
    Trifilieff, P.
    Feng, B.
    Urizar, E.
    Winiger, V.
    Ward, R. D.
    Taylor, K. M.
    Martinez, D.
    Moore, H.
    Balsam, P. D.
    Simpson, E. H.
    Javitch, J. A.
    MOLECULAR PSYCHIATRY, 2013, 18 (09) : 1025 - 1033
  • [4] Increasing dopamine D2 receptor expression in the adult nucleus accumbens enhances motivation
    P Trifilieff
    B Feng
    E Urizar
    V Winiger
    R D Ward
    K M Taylor
    D Martinez
    H Moore
    P D Balsam
    E H Simpson
    J A Javitch
    Molecular Psychiatry, 2013, 18 : 1025 - 1033
  • [5] Epigenetic Regulation of Dopamine D2 Receptor in the Core of the Nucleus Accumbens Contributes to Addiction Liability
    Flagel, Shelly B.
    Chaudhury, Sraboni
    Waselus, Maria
    Watson, Stanley J.
    Akil, Huda
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S296 - S297
  • [6] Brain stimulation reward is affected by D2 dopamine receptor manipulations in the extended amygdala but not the nucleus accumbens
    Waraczynski, Meg
    Salemme, Jennifer
    Farral, Benjamin
    BEHAVIOURAL BRAIN RESEARCH, 2010, 208 (02) : 626 - 635
  • [7] Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic
    Keck, PE
    McElroy, SL
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (04) : 655 - 662
  • [8] α-Synuclein enhances dopamine D2 receptor signaling
    Kim, Sung Jae
    Kim, Sung Yul
    Na, Young-Soon
    Lee, Hyun Jung
    Chung, Kwang Chul
    Baik, Ja-Hyun
    BRAIN RESEARCH, 2006, 1124 : 5 - 9
  • [9] New Concepts in Dopamine D2 Receptor Biased Signaling and Implications for Schizophrenia Therapy
    Urs, Nikhil M.
    Peterson, Sean M.
    Caron, Marc G.
    BIOLOGICAL PSYCHIATRY, 2017, 81 (01) : 78 - 85
  • [10] Dopamine D2/D3-receptor and transporter densities in nucleus accumbens and amygdala of type 1 and 2 alcoholics
    E Tupala
    H Hall
    K Bergström
    T Särkioja
    P Räsänen
    T Mantere
    J Callaway
    J Hiltunen
    J Tiihonen
    Molecular Psychiatry, 2001, 6 : 261 - 267